RGEN
Repligen Corp
Price:  
150.54 
USD
Volume:  
225,812.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-90.4%
Upside

As of 2024-12-05, the Relative Valuation of Repligen Corp (RGEN) is 14.41 USD. This relative valuation is based on P/E multiples. With the latest stock price at 150.54 USD, the upside of Repligen Corp based on Relative Valuation is -90.4%.

The range of the Relative Valuation is (7.96) - 39.05 USD.

Range Selected
Trailing P/E multiples 29.6x - 33.2x 33.0x
Forward P/E multiples 31.5x - 34.1x 32.9x
Fair Price (7.96) - 39.05 14.41
Upside -105.3% - -74.1% -90.4%
150.54 USD
Stock Price
14.41 USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2024-11-14 -552.31
2024-11-13 -560.60
2024-11-12 -553.59
2024-11-11 -519.76
2024-11-08 -524.20
2024-11-07 -536.05
2024-11-06 -543.68
2024-11-05 -543.76
2024-11-04 -519.84
2024-11-01 -516.41
2024-10-31 -500.24
2024-10-30 -508.10
2024-10-29 -502.48
2024-10-28 -511.20
2024-10-25 -504.64
2024-10-24 -503.63
2024-10-23 -512.20
2024-10-22 -537.01
2024-10-21 -555.90
2024-10-18 -547.48
2024-10-17 -529.56
2024-10-16 -514.77
2024-10-15 -540.14
2024-10-14 -532.95
2024-10-11 -517.19
2024-10-10 -501.06
2024-10-09 -508.74
2024-10-08 -503.04
2024-10-07 -508.89
2024-10-04 -509.33
2024-10-03 -518.01
2024-10-02 -533.62
2024-10-01 -542.98
2024-09-30 -554.45
2024-09-27 -543.68
2024-09-26 -548.34
2024-09-25 -520.10
2024-09-24 -532.21
2024-09-23 -523.19
2024-09-20 -532.66
2024-09-19 -543.12
2024-09-18 -529.15
2024-09-17 -508.14
2024-09-16 -521.59
2024-09-13 -521.55
2024-09-12 -528.78
2024-09-11 -534.26
2024-09-10 -546.55
2024-09-09 -538.32
2024-09-06 -547.93